Journal: Oncogene
Article Title: ZEB1-repressed microRNAs inhibit autocrine signaling that promotes vascular mimicry of breast cancer cells
doi: 10.1038/onc.2017.356
Figure Lengend Snippet: Increased expression of FN1 and SERPINE2 is regulated by serum withdrawal and is essential for VM. ( a ) Quantitative reverse transcription–PCR (qRT–PCR) in breast cancer cell lines cultured with 10 or 0% serum for 48 h. Error bars represent s.d. of three independent experiments. T -tests were performed for each line comparing 0vs10% conditions, ** P <0.01, *** P <0.001. ( b , d ) Representative images of VM in control and FN1 ( b ) or SERPINE2 ( d ) knockdown cells. Scale bars=1000 μm. ( c , e ) Quantification of total network length for VM assays as shown in b and d . Error bars represent s.d. for at five and four independent experiments, respectively. T -tests were performed to compare each to siNT control, ** P <0.01. ( f ) Representative images of VM in control and FN1 or SERPINE2 knockdown in BT-549 cells. Scale bars=1000 μm. ( g ) Quantification of total network length. Error bars represent s.d. for three independent experiments. T -tests were performed to compare each to siNT control, * P <0.05. ( h ) Representative phase images of cell morphology in siNT or siSERPINE2 cells. Scale bars=100 μm. ( i ) qRT–PCR for FN1 and CDH1 in cells transfected with siNT or siSERPINE2. Error bars represent s.d. of three independent experiments. T -test was performed, *** P <0.001. ( j ) qRT–PCR for FN1 and SERPINE2 in cells transfected with NEG or clustered miRNA mimics for 48 h, then cultured with 10 or 0.5% serum for 48 h. Error bars represent s.d. of three independent experiments. T -tests were performed comparing 0.5vs10% in the control or comparing cells transfected with miRNAs vs NEG in matching serum conditions, *** P <0.001. ( k ) Western blot for FN1 for cells as in h . ACTB is loading control. ( l , m ) Quantification of total network length of VM assays from VM-incompetent cells plated in 0% serum ( l ) or VM-competent cells plated in 5% serum ( m ) in the presence or absence of recombinant FN1 and SERPINE2 as shown. Error bars represent s.d. of two independent experiments.
Article Snippet: Recombinant FN1 (1918-FN-02M, R&D Systems, Minneapolis, MN, USA) and SERPINE2 (2980-PI-010, R&D Systems) were added to VM assays at concentrations of 1 and 10 μg/ml, respectively.
Techniques: Expressing, Reverse Transcription, Quantitative RT-PCR, Cell Culture, Control, Knockdown, Transfection, Western Blot, Recombinant